Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 26, 2020

BUY
$3.01 - $3.88 $22,575 - $29,100
7,500 New
7,500 $24,000
Q2 2020

Aug 05, 2020

SELL
$2.33 - $4.6 $4,660 - $9,200
-2,000 Closed
0 $0
Q1 2020

Apr 13, 2020

BUY
$1.91 - $4.52 $3,820 - $9,040
2,000 New
2,000 $5,000

Others Institutions Holding MBIO

About MUSTANG BIO, INC.


  • Ticker MBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,222,000
  • Market Cap $24.2M
  • Description
  • Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...
More about MBIO
Track This Portfolio

Track Center Star Asset Management, LLC Portfolio

Follow Center Star Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Center Star Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Center Star Asset Management, LLC with notifications on news.